Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2004
03/04/2004WO2004017971A1 Use of a papaverine-like vasodilator and pharmaceutical composition
03/04/2004WO2004017962A2 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
03/04/2004WO2004017958A1 Soft capsule preparation
03/04/2004WO2004017954A1 Agent for reducing side effects of diclofenac
03/04/2004WO2004017951A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome
03/04/2004WO2004017947A1 Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets
03/04/2004WO2004017945A1 Nanoparticles for dna administration to a target organ
03/04/2004WO2004017944A1 Liposomal gemcitabine compositions for better drug delivery
03/04/2004WO2004017943A2 Non-vesicular cationic lipid formulations
03/04/2004WO2004017942A1 Inhalation compositions with high drug ratios
03/04/2004WO2004017941A2 Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
03/04/2004WO2004017940A2 Pharmaceutically active lipid based formulation of sn38
03/04/2004WO2004017938A2 Nitrofurantoin controlled release dosage form
03/04/2004WO2004017937A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof
03/04/2004WO2004017918A2 Method of preparing dry powder inhalation compositions
03/04/2004WO2004017915A2 Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition
03/04/2004WO2004017914A2 Inhalation composition
03/04/2004WO2004017907A2 Blood clot-targeted nanoparticles
03/04/2004WO2004017903A2 Methods for treating fungal infections
03/04/2004WO2004017901A2 Compositions and methods for treating skin conditions
03/04/2004WO2004017897A2 Aripiprazole complex formulation and method
03/04/2004WO2004002445A3 Novel floating dosage form
03/04/2004WO2003101427A8 Immunoliposomes formed with aggregated antibody
03/04/2004WO2003095012B1 Method and apparatus for vaporizing a compound
03/04/2004WO2003079993A3 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
03/04/2004WO2003075888A3 Materials containing multiple layers of vesicles
03/04/2004WO2003072143A9 Compositions for delivery of therapeutics and other materials, and methods of making and using the same
03/04/2004WO2003060076A3 Povidone-containing carriers for polypeptide growth factors
03/04/2004WO2003055442A3 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
03/04/2004WO2003053498A3 Medication delivery system and monitor
03/04/2004WO2003053463A3 Poxvirus-containing compositions and process for their preparation
03/04/2004WO2003053180A3 Undergarments containing active substances
03/04/2004WO2003051286A3 Hydrogel compositions, devices, and microscale components
03/04/2004WO2003043574A3 Pharmaceutical compositions in particulate form
03/04/2004WO2003041687A3 Method for producing stable solutions of phenolic substances and resulting solutions
03/04/2004WO2003039566A3 Methods of treatment in situ in the lungs of mammals
03/04/2004WO2003032904A3 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
03/04/2004WO2003026629A3 Modified release dosage forms
03/04/2004WO2003026581A3 Pharmaceutical compositions and methods for treating cancer
03/04/2004WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces
03/04/2004WO2003005961A3 A controlled release biodegradable gel matrix
03/04/2004WO2003000310A9 Nasal devices
03/04/2004WO2002094178A3 Treatment of renal fibrosis
03/04/2004WO2002085248A3 Prostanoids augment ocular drug penetration
03/04/2004WO2002072606A3 Epitope testing using hla
03/04/2004WO2002066000A3 Novel cosmetic slimming compositions containing boldine
03/04/2004WO2002047664A8 Microparticles with an improved release profile and method for the production thereof
03/04/2004WO2002036158A8 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
03/04/2004WO2002015938A8 Testosterone ester formulation for human use
03/04/2004US20040044408 Cell-culture and polymer constructs
03/04/2004US20040044332 Implantable medical device for delivering a liquid
03/04/2004US20040044306 Pivoting joint infusion system with seal
03/04/2004US20040044241 Novel succinate salt of O-desmethyl-venlafaxine
03/04/2004US20040044196 Derivatised carbohydrates and their use in solid delivery systems
03/04/2004US20040044185 Comprises transmembrane protein for use in liposome-based drug and nucleotide delivery systems; gene therapy
03/04/2004US20040044086 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism
03/04/2004US20040044082 Adrenergic receptor antagonist
03/04/2004US20040044080 Treatment of dyspareunia with topically administered nitroglycerin formulations
03/04/2004US20040044078 Cosmetic and/or pharmaceutical emulsions
03/04/2004US20040044070 Cardiovascular disorders; antiarrhythmia agents
03/04/2004US20040044035 Antiallergens; rhinitis
03/04/2004US20040044020 Respiratory system disorders; antiinflammatory agents
03/04/2004US20040043996 Controlled release formulation of lamotrigine
03/04/2004US20040043981 Pharmaceutical composistions
03/04/2004US20040043980 Bactericides; storage stability
03/04/2004US20040043964 Cellulosic particle for pharmaceuticals preparation
03/04/2004US20040043954 Liposomes
03/04/2004US20040043952 Complex of lipid and pentaerythritol; supplying nucleic acids to cells; transfection cells; drug delivery
03/04/2004US20040043945 Crystal forms of azithromycin
03/04/2004US20040043944 Form of azithromycin selected from the group consisting of forms D, E, substantially pure F, G, J, M substantially in the absence of azithromycin dihydrate, N, O, P, Q, and R; NMR spectrun analysis; bactericides; antiprotozoa agents; infections of mammals, birtds, and fish; drug resistance
03/04/2004US20040043943 Method for the management of incontinence
03/04/2004US20040043925 Cyclic depsipeptides; veterinary medicine
03/04/2004US20040043171 Transdermal drug delivery
03/04/2004US20040043079 Microencapsulated materials and method of making same
03/04/2004US20040043078 Encapsulation of emulsions
03/04/2004US20040043077 Production of microspheres
03/04/2004US20040043076 Containing protein active material; solvent-free
03/04/2004US20040043075 Topical applying; vision defects
03/04/2004US20040043073 Mixture of wax and drug; sustained release
03/04/2004US20040043071 Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs
03/04/2004US20040043070 Hot melt coating by direct blending and coated substrates
03/04/2004US20040043069 Stable oral formulation containing benzimidazole derivative
03/04/2004US20040043068 Supplying nitrogen oxide to vascular system; prevent restenosis; cardiovascular disorders; antiischemic agents
03/04/2004US20040043067 Fluorosiloxane matrix controlled diffusion drug delivery systems
03/04/2004US20040043066 Levothyroxine compositions having unique triiodothyronine Tmax properties
03/04/2004US20040043065 Controlled release formulations containing an active ingredient, preferably melatonin, and the method of preparation
03/04/2004US20040043064 Active material enclosured in impervious layer; capsule
03/04/2004US20040043062 Containing herbs; transdermal; sustained release
03/04/2004US20040043061 Dissolvable films comprising suspended, non-soluble pharmaceutically active ingredients, apparatus and methods for their manufacture and use
03/04/2004US20040043059 Flat sheet with adhesive substrate; convex frame; aging and oxidation resistance
03/04/2004US20040043043 Gelling, thickening solutions of water soluble vitamins with triglycerides and emulsifiers
03/04/2004US20040043041 Antimicrobial compositions and methods of use
03/04/2004US20040043038 Vaccines
03/04/2004US20040043007 Transfection system
03/04/2004US20040043006 Tissue regenerative composition
03/04/2004US20040043003 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
03/04/2004US20040043001 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same
03/04/2004US20040042973 Anhydrous mometasome furoate mixture with surfactant and propellant; pressurized vessel; controlling particle size distribution
03/04/2004US20040042972 Spray freeze dry of compositions for intranasal administration
03/04/2004US20040042971 Spray freeze dry of compositions for pulmonary administration